Iconic cannabis brand Cookies has partnered with Israel-based InterCure to expand into Europe.
The partnership will see Cookies and InterCure open retail locations in the UK and Austria in early 2022. The parties entered into a multi-year deal under which InterCure will establish Cookies stores and medical cannabis pharmacies in the countries.
President of Cookies, Parker Berling, commented: “As we focus on new territories, it’s vital our customers continue to count on the quality Cookies is known for, which is a value we share with our partners at InterCure.
“We look forward to reaching audiences in Austria and the United Kingdom and establishing Cookies as a mainstay in each community.”
InterCure, a Cookies’ international partner, is already cultivating, manufacturing and distributing GMP standard, Cookies-branded products through its Cookies national medical cannabis pharmacy chain. InterCure will leverage its licensed international supply chain to serve the growing communities of medical cannabis patients in Europe.
CEO of InterCure, Alexander Rabinovitch, added: “Cookies is one of the most internationally recognized brands in cannabis, and after our mutual success in Israel, it’s only obvious we further our expansion to Europe, providing the highest quality grade cannabis products.”
Cookies recently announced its partnership with The Flowr Corporation to bring its premium strains such as Pink Runtz and Gelatti to the European Union. The partnership will see Flowr’s indirect wholly-owned subsidiary, RPK Biopharma, cultivate and distribute Cookies products in Portugal from its 25,000 square foot indoor EU GMP facility in Sintra.